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Clinical and Para clinical Manifestations of Tuberous Sclerosis: A Cross 
Sectional Study on 81 Pediatric Patients 
Abstract
Objective
Tuberous sclerosis complex is an autosomal dominant neurocutaneous disease that 
presents with dermatological, neurological, cardiac, renal and ocular symptoms. 
We described the variable clinical manifestations, neuroimaging findings, Age and 
sex distribution of tuberous sclerosis in a group of 81 patients referred to our clinic.
Materials & Methods
Based on the diagnostic criteria, totally 81 tuberous sclerosis patients with sufficient 
data were enrolled into the study. These children were referred by child neurologists.
Results
The mean age of the patients was 52 months (range, 7-180 months). There were 28 
girls and 53 boys. A positive familial history of TSC was seen in 29.6% of the patients.
Hypo pigmented macules were the most common manifestation (82.7%). Facial 
angiofibroma, shagreen patches, café-au-lait lesions and seizure were observed in 
32.1%, 12.3%, 7.4%. and 74.1% of the studied cases, respectively. Infantile spasm was 
present in the clinical course of 32.1 % of the patients.
Cortical tubers were the most common MRI finding which were seen in 21 cases 
(25.9%). Subepandymal giant cell astrocytoma was seen in four (4.9%) patients and 
intracranial calcification (detected by CT scan) was observed in 18 (22.2%) of the 
patients.
Conclusion
Dermatological and neurological findings were the most common symptoms in 
tuberous sclerosis with a significant correlation between them. Thus, careful skin 
examination is necessary in epileptic patients for detection of the mentioned lesions.
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Introduction
Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous 
disease (phacomatosis) with variable clinical manifestations (1). The incidence of 
the disease is approximately 1/6000- 1/10000 (2, 3).
Diagnosis is based on clinical and paraclinical criteria defined by the tuberous 
sclerosis consensus conference in 1998 .There are two groups of symptoms including 
major and minor criterias.The major criterias consist of:Facial angiofibromas or 
forehead plaques, Nontraumatic ungula or periungual fibroma, Hypopigmented 
macules (more than 3), Shagreen patch, Cortical tubers, Subepandymal nodules, 
Subepandymal giant cell astrocytoma, Multiple retinal nodular hamartomas, 
Cardiac rhabdomyoma, Lymphangiomyomatosis and renal angiomyolipoma.The 
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minor criterias include:Dental Pits (more than 14), 
Hamartomatous rectal polyps, Bone cysts, Cerebral whte 
matter radial migration lines, Nonrenal hamartomas, 
Retinal achromatic  patch, Confetti skinlesions, Multiple 
renal cysts.When there are two major criteria or one 
major and two minor criteria the diagnosis is established 
as definite TSC. The term probable TS is used when 
one major and one minor criteria are detected (2). Only 
one major feature or two or more minor criteria without 
any major feature mentions the possibility of tuberous 
sclerosis (2).
The central nervous system involvement is the most 
common finding in tuberous sclerosis that leads to 
morbidity and mortality (4). These manifestations were 
first described by D M Bourneville in 1880. Before 
that, Von Recklinghausen had described a newborn 
who had died of respiratory distress and at post mortem 
examinations a great number of cerebral sclerosis was 
detected (3).
Epilepsy is the most common presenting symptom in 
tuberous sclerosis. In 98% of these patients seizure is 
discovered and 75% of them have a seizure attack in the 
first year of life (4). Seizure control is difficult and they 
tend to be refractory and intractable in more than 50% of 
the cases despite pharmacological and surgical treatment 
(5). Even cases with a good response to antiepileptic 
drugs in the beginning of therapy will have frequent 
relapses (6). 
Surgery is one of the treatment options of seizures, but 
the outcome is best when the EEG-MRI and semiology 
of seizure indicate a surgically accessible location (6). 
Recent reports on the direct approach to neoplastic 
lesions show that in cases with an increased intracranial 
pressure, surgical interventions may provide a better 
outcome (7). Surgery is not indicated in the presence 
of bilateral epileptogenic zones, progressive epileptic 
encephalopathy and severe mental retardation. 
In some cases with drug resistant epilepsy and those 
who are waiting for surgical intervention, the ketogenic 
diet has been considered. This diet can decrease more 
than 50%of seizures in 90% of cases (8). It seems 
that antiepileptic treatment before the onset of seizure 
reduces the severity of epilepsy and the risk of mental 
retardation in TSC if EEG shows multifocal activity 
without clinical seizure (9).
Other neurological manifestations of TSC include 
cortical tubers (Fig 1), subepandymal nodules (Fig 2) 
and subepandymal giant cell astrocytoma that may lead 
to seizure attacks. Cortical tubers tend to be in the front 
parietal region. Ventricular dilation is seen in 55% of TS 
cases and cerebral tumors in 1.7-15% with a mean age 
of 13.5 years (11).
The skin manifestations of TSC tend to be the most 
prevalent findings (4). The hypo pigmented macules or 
ash leaf lesions are the most important, early onset and 
characteristic dermatological findings (Fig 3). These 
lesions are seen in 4.7% of the normal population, but 
their prevalence is 97% in children with TSC (4). They are 
located on the trunk and buttocks and are easily identified 
with the wood lamp. Other skin lesions such as café-au-
lait macules, confetti like macules, periungual fibromas, 
forehead plaques and shagreen patches may also be 
observed. The latter is seen soon before puberty (3).
Sometimes cardiac rhabdomyoma is the earliest 
diagnostic finding in TSC. These hamartomas of the 
heart remain asymptomatic and regress in size and 
number till 6 years of age in 58-74% of the patients (4). 
Renal involvement is seen as angiomyolipomas (AML) 
or cysts in TSCs. They are the second cause of death in 
these patients and the first fatal cause in patients older than 
30 years of age. AML is the most common major renal 
finding and is often bilateral. Only a fair correlation was 
found between age and renal involvement (12). Ocular 
manifestations of TSC including retinal hamartomas 
occur in less than 50% of the patients and are bilateral 
in one third of the cases. There is no correlation between 
age and ocular manifestations (2).
Materials & Methods
Eighty-one children (age range: 7 months to 15 years) 
based on the diagnostic criteria and sufficient data were 
enrolled into the study.
These children were referred by dermatologists and 
child neurologists practicing in Tehran and other cities 
to the neurology clinic of Mofid children hospital from 
September 2009 till July 2012. Clinical and paraclinical 
information based on careful physical examination and 
systematic review of the patients were collected by a 
fellow in child neurology. 
This information was collected on a questionnaire and 
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statistically analyzed by SPSS 12 package. Informed 
consent for collecting and publishing patients’ 
information was obtained from the parents. 
Results
The mean age of the patients at diagnosis was 52 months 
(age range, 7 to 180 months), the median was 48 months 
and sex distribution was 28 (34.6%) female and 53 
(65.4%) male. Eleven patients (13.6%) were under 1 
years, 38 patients(46.9%) between 1 and 5 years, 24 
cases (29.6%) between 5 and 10 years and eight (9.9%) 
were between 10 and 15 years.
A positive familial history of TSC was observed in 24 
patients (29.6%). Sixteen families had a consanguineous 
marriage (19.8%) which is a normal finding in the 
Iranian population.
The most common manifestation of disease, hypo 
pigmented macules (ash-leaf) were seen in 67 of the 
patients (82.7%). Other dermatological manifestations 
were less common. Shagreen patches were detected 
in ten (12.3%), café-au-lait lesions in 7.4% and facial 
angiofibroma in3.2% of our study group.
Seizure was found in 60 patients (74.1%) and 32.1% 
of our study group had infantile spasm in their clinical 
course. The mean age of onset for infantile spasm 
was 5 months. The most common MRI finding was 
cortical tubers that were observed in 21 cases (25.9%). 
Subepandymal giant cell astrocytoma was found in four 
(4.9%) and intracranial calcification (detected by CT 
scan) was detected in 18 patients (22.2%) (table 1).
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Table 1. Clinical and Paraclinical Manifestations of Tuberous Sclerosis in Our Study Group
Manifestation Number Percentage
Ophthalmological Symptoms
Retinal hamartoma 1 1.2%
Achromatic retinal patches 0 0%
Retinal astrocytoma 1 1.2%
Optic glioma 0 0%
Cardiological Symptoms
Wolf-Parkinson-White syndrome 0 0%
Cardiac rhabdomyoma 18 22.2%
Renal Symptoms
Renal cysts 5 6.2%
Tumors of the Kidney 3 3.7%
Dermatological Symptoms
Forehead plaques 2 2.5%
Facial angiofibroma 26 32.1%
Ashleaf macules 67 82.7%
Shagreen patch 10 12.3%
Café-au-lait 6 7.4%
Subungual fibroma 5 6.2%
Skin tag 0 0%
Confetti skin lesion 6 7.4%
Poliosis 0 0%
Imaging Findings
Hamartomatous lesions of the brain 3 3.7%
Cortical tubers 21 25.9%
Subepandymal giant cell astrocytoma 4 4.9%
Intracranial calcification 18 22.2%
CNS Symptoms
Infantile spasm 26 32.1%
Seizure 60 74.1%
Mental retardation 13 6%
Learning difficulties 9 11.1
Endocrine Symptoms
Precocious puberty 0 0%
Hypothyroidism 1 1.2%
28 Iran J Child Neurology Vol 6 No 3 Summer  2012
Clinical and Para clinical Manifestations of Tuberous Sclerosis: A Cross Sectional Study on 81 Pediatric Patients 


 
 
 
 
 
 
      
                               
 
 
                                                                                Fig 3. Ashleaf macules
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Fig 1. Cortical tubers 
Cardiac rhabdomyoma was seen in 18 patients 
(22.2%). No other cardiologic involvement (such as 
Wolf -Parkinson -White syndrome) was seen in our 
study. Ophthalmological involvements were found in 
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 Fig 2. Subepandymal nodules  & Cortical tubers       
two patients (one retinal hamartoma and one retinal 
astrocytoma). Renal problems were seen in eight cases 
including five cases of renal cysts (6.2%) and three cases 
of kidney tumors (3.7%) 
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sign of disease in our study, were seen in 82.7% of the 
cases. This sign was observed in 90-95% of the cases in 
prior studies. Considering the tendency of these lesions 
to disappear in adulthood, we expected more prevalence 
in our study due to the age distribution of the study group 
(2-4). 
We found facial angiofibroma in 3.2% of the children. 
These lesions do not typically appear before the age 
of 3-4 years (2). In our study, the mean age of patients 
with angiofibroma was 46 years. Shagreen patches were 
observed in 12.3% of the patients. In other studies, the 
frequency of this finding was about 20-30% (15). These 
lesions are late onset lesions and usually appear soon 
before puberty. The mean age of shagreen patches in our 
patients was 76 months which is compatible with other 
studies.
Although lesions such as shagreen patches and facial 
angiofibroma are age dependent based on prior studies 
(2-4), we did not find any correlation between the age 
group and these lesions.
Other skin findings were less common probably due to 
the patient age distribution in our study group and they 
Discussion
The mean age of diagnosis in our study was 51 months 
and the median was 48 months. These parameters show 
a normal age distribution pattern. In prior studies, the 
mean age of diagnosis was higher than our study despite 
the lower median age (2). We think this difference is due 
to the age distribution of our study group. We performed 
our study in the pediatric group and other studies relied 
on all age groups so a different distribution was observed.
Thirty percent of our patients (27 cases) had a positive 
familial history. In 11 cases, the mother and in 13 cases, 
the father were affected and in three cases, the siblings 
were affected without parental involvement. These show 
that despite the autosomal dominant pattern of tuberous 
sclerosis transmission, in many of the cases, it is the 
result of new mutations. In prior studies, the prevalence 
of sporadic tuberous sclerosis was 60-70% of the cases 
based on genetic (TSC1 or TSC2) (2, 13). 
 Only 1/5 of our patients were products of consanguineous 
marriage that is lower than the expected rate in the 
Iranian population (34-44%) (14).
Hypo pigmented macules, the most common presenting 
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Fig 4. Age distribution of tuberous sclerosis patients in our study
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We found a strong correlation between CNS involvement 
and skin manifestation in our study. This is also consistent 
with prior studies (15).
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